🇺🇸 FDA

Company profile · Sponsor

Teva

Teva Generics B.V

EC84A18 · EMA pharma EU
Pipeline
4
Drugs
0
Patents
0

Quick answer

Teva (EC84A18) is a pharma company. headquartered in EU. listed on EMA. NovaPharmaNews links 4 pipeline programs, 0 drugs, and 0 patents to this profile..

Company facts

Ticker EC84A18
Exchange EMA
Company type pharma
Headquarters EU

Pipeline (4)

Search pipeline →

  1. Reslizumab

    Teva

    Eosinophilic Asthma

    phase 3 small molecule terminated

    1 trial

  2. TEV-56248

    Teva

    Asthma

    phase 3 small molecule active

    1 trial

  3. CEP-18770

    Teva

    Multiple Myeloma

    phase 2 small molecule completed

    1 trial

  4. Modakafusp Alfa

    Teva

    Neoplasms

    phase 2 small molecule terminated

    1 trial

Frequently asked questions

What is Teva?

Teva (EC84A18) is a pharma company. headquartered in EU. listed on EMA. NovaPharmaNews links 4 pipeline programs, 0 drugs, and 0 patents to this profile..

What pipeline programs does Teva sponsor?

We track 4 ClinicalTrials.gov-linked programs for Teva, including Reslizumab and 3 more. Open each program for phase, modality, NCT IDs, and indication details.

Where does Teva company data come from?

Profiles combine SEC EDGAR (CIK/ticker), ClinicalTrials.gov sponsor links, FDA drug records, and USPTO patent metadata. See our data sources page. This profile is for professional reference, not investment advice.